SAN LUIS OBISPO, Calif., Nov. 15, 2017 /PRNewswire/ -- Available for immediate shipment from Applied Biotechnology Institute (ABI) (www.appliedbiotech.org), is TRYPZEAN®, the leading non-animal recombinant alternative to bovine or porcine trypsin. This non-animal source recombinant is:
- Certified animal-free which eliminates the risk of animal-source contaminants such as viruses and bovine spongiform encephalopathy (BSE)
- Free of other proteases
- High purity and free of contaminants associated with animal-sourced trypsin and therefore can be used in lower concentrations in some applications
TRYPZEAN® is ideal in any number of applications including:
- Cell culture where TRYPZEAN® provides dissociation of attachment
- Manufacturing of vaccines and therapeutics for both human and veterinary applications
- Any applications where there is a risk of animal-source products subject to recalls
There are several technologies for production of proteins that have been in place for decades using microbial and animal cell cultures; however, each of these systems has its limitations. ABI takes advantage of the unique characteristics found in plant systems to overproduce recombinant proteins. The company selects proteins that are not well-suited to traditional expression systems. The chosen system is maize grain, for which ABI has issued and pending patents that favor high expression and efficient processing. The ABI platform has many advantages including low cost of production, low upfront capital costs, animal-free products, no purification required, ability to store proteins for long periods and proven commercial potential.
For full product specifications and pricing/order information contact: firstname.lastname@example.org.
About Applied Biotechnology Institute: Applied Biotechnology Institute (ABI) is dedicated to providing health and environmental benefits to society. ABI uses its proprietary animal-free system to produce recombinant proteins and develop sustainable solutions. The company forms partnerships with other companies for latter stages of product development, production and sales, and encourages partner discussions.
View original content with multimedia:http://www.prnewswire.com/news-releases/a-non-animal-sourced-recombinant-alternative-to-bovine-trypsin-300556293.html
SOURCE Applied Biotechnology Institute